Biochemical markers for myocardial infarction used in combination with clinical decision limits. Influence of S-myoglobin on the predictive values.
To predict the development of an acute myocardial infarction (AMI) in a patient with chest pain or other symptoms compatible with myocardial infarction is a difficult clinical problem. In this study of 927 consecutive patients with a suspected AMI symptoms selected by the Multicenter Chest Pain Study Group were tested. An equation was constructed based on five of the most significant variables found. In a subgroup of 305 patients the additional value of S-Myoglobin was tested and found to be valuable for the decision of further handling of the patient with suspected AMI.
Department of Internal Medicine, Sundsvall Hospital, Sweden.
B H
BH
Möller
A
A
Hamfelt
D000368:Aged; D015415:Biomarkers; D003422:Critical Care; D004562:Electrocardiography; D005260:Female; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000175:diagnosis* / Q000453:epidemiology / Q000378:metabolism*; D009211:Myoglobin / Q000097:blood*; D011237:Predictive Value of Tests; D015995:Prevalence; D012044:Regression Analysis; D012307:Risk Factors; D012680:Sensitivity and Specificity
D015415:Biomarkers; D009211:Myoglobin